Clinical Trials Directory

Trials / Completed

CompletedNCT07220200

MOVE Protocol - Movement-Oriented Velocity of Engagement

A Prospective, Multi-Site, Interventional Case-Series Evaluating the MOVE (Movement-Oriented Velocity of Engagement) Protocol for Musculoskeletal Pain Recovery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
MMSx Authority Institute for Movement Mechanics and Biomechanics Research Inc · Unknown
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

A Prospective, Multi-Site, Interventional Case-Series Evaluating the MOVE (Movement-Oriented Velocity of Engagement) Protocol for Musculoskeletal Pain Recovery

Detailed description

The MOVE Protocol is a structured, biomechanics-based rehabilitation framework designed to accelerate recovery from musculoskeletal pain conditions through progressive mobilization and neuromuscular control. This interventional case-series involved multiple clinical and training centers (BodyGNTX, GFFI, IIKBS, ASFU) and applied standardized MOVE sessions under the supervision of certified movement specialists. Assessments included pain scoring (NRS), functional mobility (LEFS/UEFI), and balance control, measured at baseline, week 2, week 4, and week 8. The protocol followed ICH-GCP E6(R2) and Helsinki 2013 guidelines, with institutional ethics approval from MMSx Authority IREB. The study demonstrated safe and effective early-movement outcomes across diverse populations, emphasizing mobility, load optimization, and neuromuscular revalidation.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMOVE Rehabilitation ProtocolThe MOVE (Movement-Oriented Velocity of Engagement) protocol is a biomechanics-based rehabilitation approach targeting early mobilization and functional recovery for musculoskeletal pain conditions. The structured program includes four key phases: Mobilize, Optimize Load, Validate Neural Control, and Energize Recovery, applied over 8 weeks under therapist supervision.

Timeline

Start date
2024-06-15
Primary completion
2024-10-10
Completion
2025-10-17
First posted
2025-10-23
Last updated
2025-10-23

Locations

4 sites across 2 countries: United States, India

Source: ClinicalTrials.gov record NCT07220200. Inclusion in this directory is not an endorsement.